Prediabetes drug study pulled before it began
NCT ID NCT06526494
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to test whether metformin, a common diabetes drug, could improve blood vessel function in people with prediabetes. It planned to enroll adults aged 18-55 with prediabetes and compare metformin to a placebo over 12 weeks. However, the study was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREDIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52245, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new rice could tame blood sugar spikes in prediabetes
- Could everyday supplements turn back the clock on aging?
- Can a single pill tackle both fatty liver and diabetes?
- Does when you eat carbs and protein reshape blood sugar control?
- Could a daily glass of milk help ward off type 2 diabetes?
- Can one avocado a day sharpen the aging brain?